Skip to content

Evaluation of the effect of Medonex on patients undergoing open heart surgery

Evaluation of the effect of Medonex on hemodynamics of patients undergoing coronary artery bypass grafting

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20130428013159N13
Enrollment
78
Registered
2023-04-15
Start date
2023-01-10
Completion date
Unknown
Last updated
2023-05-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IHD. Acute transmural myocardial infarction - Acute subendocardial myocardial infarction

Interventions

Intervention 1: Intervention group:in the intervention group, Medonex is diluted in saline with a concentration of 0.1 µg/kg/ml. Start with an infusion pump: within 10 minutes as a loading dose (1 µg/

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 75 Years

Inclusion criteria

Inclusion criteria: Patients aged 35 to 75 referring to eduacational medical hospital ASA class II Candidates for coronary bypass surgery with an elective cardiopulmonary pump,

Exclusion criteria

Exclusion criteria: Emergency operation Simultaneous heart valve operation Underlying lung or liver or kidney, thyroid or gastrointestinal disease (nausea-vomiting-diarrhea) History of previous heart surgery Fever Trauma Carotid artery occlusion Diabetes Difficult and longer intubation than 20 seconds BMI more than 30 kg/m2 Patient with heart rate less than 50 per minute History of heart bundle block History of treatment with clonidine and methyldopa Ejection fraction less than 35%

Design outcomes

Primary

MeasureTime frame
Mean arterial pressure and heart rate and hemodinamic parameters in the attached tables at the end of the proposal. On entering the operating room, basic and hemodinamic information (T1) was recorded and at the time, 15 minutes after tracheal intobation (T2) and at the time, 15 minutes after From the sternotomy (T3) and 15 minutes after the start of the cardiopulmonary bypass pump (T4) and 30 minutes after disconnecting from the cardiopulmonary bypass pump (T5) by the anesthesia assistant, the dose is recorded in the checklist. Total propofol, sufentanil, fentanyl, epinephrine, dobutamine, nitroglycerin, norepinephrine, and atropine are recorded in the checklist at the end of the procedure. Timepoint: Mean arterial pressure and heart rate and hemodynamic parameters in the attached tables at the end of the proposal. On entering the operating room, basic and hemodynamic information (T1) was recorded and at the time, 15 minutes after tracheal intubation (T2) and at the time, 15 minutes after From the sternotomy (T3) and 15 minutes after the start of the cardiopulmonary bypass pump (T4) and 30 minutes after disconnecting from the cardiopulmonary bypass pump (T5) by the anesthesia assistant, the dose is recorded in the checklist. Total propofol, sufentanil, fentanyl, epinephrine, dobutamine, nitroglycerin, norepinephrine, and atropine are recorded in the checklist at the end of the procedure. Method of measurement: Checklist for measuring vital signs from monitoring USCOM.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShima Sheybani

Mashhad University of Medical Sciences

sheybanish@mums.ac.ir+98 51 3840 0000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026